The following is a summary of “Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging ...

Mild asthma attacks may last a few minutes, while moderate to severe asthma attacks can last for hours or days. Early Warning Signs of an Asthma Attack Asthma attacks sometimes begin with subtle ...

Chime Biologics is committed to enabling Mabgeek in its strategic entry into the U.S. market and will continue to provide comprehensive CMC and regulatory support for the start of the Phase III ...

An asthma attack is an episode where you experience a worsening of asthma symptoms. Asthma is a chronic lung disease that causes inflamed and narrowed airways, making breathing difficult.

The SARS-CoV-2 pandemic interrupted much respiratory research. Respiratory clinical academics joined colleagues in providing clinical care, and global research efforts were directed to finding new ...

It was originally approved in 2003 for the treatment of moderate to severe asthma. The drug was subsequently granted marketing authorization to treat chronic spontaneous urticaria and ...

The FDA is set to give its decision on SNY and REGN's sBLA for Dupixent for bullous pemphigoid by June 20, 2025.

Dupixent is considered the main competitor, as it is approved for moderate and severe asthma patients, but showed limited activity in severe asthma patients with low eosinophil levels. AZ and ...